School of Medicine
Showing 10,181-10,200 of 13,053 Results
-
Niraj Sehgal
Clinical Professor, Medicine
Current Research and Scholarly InterestsQuality Improvement & Patient Safety, Teamwork & Communication, Leadership
Development, Organizational Culture & Change -
Carolyn Dacey Seib, MD, MAS
Associate Professor of Surgery (General Surgery)
BioDr. Carolyn Dacey Seib is a fellowship-trained endocrine surgeon and board-certified general surgeon who specializes in surgery of the thyroid, parathyroid, and adrenal glands. In 2025, she was among the first surgeons in the United States to earn a Focused Practice Designation in Complex Thyroid and Parathyroid Surgery from the American Board of Surgery, reflecting her expertise in these procedures and related patient management.
Dr. Seib provides comprehensive and personalized care for patients with thyroid, parathyroid, and adrenal disorders, including thyroid cancer, hyperthyroidism, primary hyperparathyroidism, primary aldosteronism, autonomous cortisol secretion, and pheochromocytomas. Her approach combines advanced surgical techniques with a focus on patient-centered outcomes, ensuring that each treatment plan is tailored to the individual.
In addition to her clinical practice, Dr. Seib is an NIH-funded researcher whose work focuses on optimizing surgical decision-making and outcomes for patients with endocrine disorders. She has received research support from the National Institute on Aging and the American Thyroid Association, and her studies have been published in leading peer-reviewed journals and featured in national media, including The New York Times.
Dr. Seib completed her undergraduate education at Princeton University (summa cum laude), earned her medical degree from the New York University School of Medicine, and completed her general surgery residency and endocrine surgery fellowship at the University of California, San Francisco (UCSF). -
Heather Selby, PhD
Basic Life Research Scientist, Stanford-Surgery Policy Improvement Research and Education Center
BioI am interested in developing medical imaging-based AI models to identify patients with locally advanced rectal cancer who achieve a clinical complete response to neoadjuvant chemoradiotherapy, with the goal of sparing them from surgery and its associated risks.
-
Zachary M. Sellers, MD, PhD
Adjunct Professor, Pediatrics - Gastroenterology
BioDr. Sellers is a pediatric physician-scientist and research and clinical development consultant. As a pediatric gastroenterologist and ion channel physiologist, Dr. Sellers' work in academia and pharma over the last 20 years has focused on improving the lives of individuals with complex and rare diseases through providing cutting-edge clinical care and advancing research and drug development. Dr. Sellers previously led a basic and translational research laboratory at Stanford, focused on epithelial ion transport and acid-base regulation using a variety of human and animal models. He is a firm believer in the exponential impact of team science and is adept working in multi-disciplinary and cross-functional teams. He seeks out strategic partnerships and opportunities that can leverage his expertise and leadership to advance innovative therapies for areas of high unmet need and to support the development of the next generation of physician-scientists. Dr. Sellers received his BS (Animal Physiology and Neuroscience) and BA (Japanese Studies) from the University of California. San Diego, his MD and PhD (Molecular and Integrative Physiology) from the University of Illinois at Urbana-Champaign, and was trained in Pediatrics and Pediatric Gastroenterology, Hepatology, and Nutrition at Stanford, where he was previously a faculty member and attending physician. He held multiple leadership positions at Stanford, including Associate Chief of Research in Gastroenterology, Director of the Stanford Children's Pancreas Program, Lead Gastroenterologist for the CF Program, Director of the CFTR Phenotyping and Theratyping Program, and Physician-Scientist Advisor for the Pediatrics Residency Program.
-
Deborah Sellmeyer
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDr. Sellmeyer is an internationally recognized expert in Metabolic Bone Disease. She is a renowned clinician who joined the Stanford faculty in 2018 as a Professor of Medicine. She has been recognized for her clinical excellence with induction into the Miller Coulson Academy of Clinical Excellence while she was at Johns Hopkins. In addition to her clinical expertise, Dr. Sellmeyer maintains a research program that centers on the effect of nutrition and environmental factors on skeletal metabolism which she has investigated through both smaller CRC-based trials and large multi-center trials. Studies she has conducted have investigated the role of dietary sodium chloride, source of dietary protein (animal, vegetable, dairy, soy), role of dietary potassium and alkaline potassium salts, targeted thoracic exercises on kyphosis, whether structured exercise can prevent bone loss in premenopausal women treated for breast cancer, and studies validating nutritional assessment questionnaires. Her expertise as a clinical researcher has enabled development of a multi-disciplinary translational research team including basic scientists in the orthopedic department, junior faculty members with K grant funding, and basic scientists in the endocrine division to develop translational projects studying the effects of osteoporosis medications on basic elements of skeletal biology utilizing bone biopsies from treated individuals as well as clinical trials of novel therapies for rare bone disorders. Dr. Sellmeyer also is a esteemed educator, having received multiple teaching awards.
